Vertex Pharmaceuticals Stock Price History
| VRTX Stock | USD 403.91 1.77 0.44% |
Below is the normalized historical share price chart for Vertex Pharmaceuticals extending back to July 24, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vertex Pharmaceuticals stands at 403.91, as last reported on the 2nd of May, with the highest price reaching 403.91 and the lowest price hitting 403.91 during the day.
If you're considering investing in Vertex Stock, it is important to understand the factors that can impact its price. Vertex Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0744, which indicates the firm had a -0.0744% return per unit of risk over the last 3 months. Vertex Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vertex Pharmaceuticals' Variance of 1.35, risk adjusted performance of (0.07), and Coefficient Of Variation of (886.16) to confirm the risk estimate we provide.
At this time, Vertex Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 23.9 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 153.1 M in 2024. . At this time, Vertex Pharmaceuticals' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 7.46 in 2024, whereas Price To Sales Ratio is likely to drop 10.12 in 2024. Vertex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 24th of July 1991 | 200 Day MA 383.972 | 50 Day MA 410.5712 | Beta 0.368 |
Vertex |
Sharpe Ratio = -0.0744
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VRTX |
Estimated Market Risk
| 1.1 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vertex Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vertex Pharmaceuticals by adding Vertex Pharmaceuticals to a well-diversified portfolio.
Price Book 5.8321 | Enterprise Value Ebitda 20.0037 | Price Sales 10.385 | Shares Float 257.6 M | Wall Street Target Price 465.42 |
Vertex Pharmaceuticals Stock Price History Chart
There are several ways to analyze Vertex Stock price data. The simplest method is using a basic Vertex candlestick price chart, which shows Vertex Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 26, 2024 | 433.48 |
| Lowest Price | April 30, 2024 | 392.81 |
Vertex Pharmaceuticals May 2, 2024 Stock Price Synopsis
Various analyses of Vertex Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Vertex Stock. It can be used to describe the percentage change in the price of Vertex Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Vertex Stock.| Vertex Pharmaceuticals Price Rate Of Daily Change | 1.00 | |
| Vertex Pharmaceuticals Price Action Indicator | 0.89 |
Vertex Pharmaceuticals May 2, 2024 Stock Price Analysis
Vertex Stock Price History Data
The price series of Vertex Pharmaceuticals for the period between Fri, Feb 2, 2024 and Thu, May 2, 2024 has a statistical range of 53.27 with a coefficient of variation of 3.02. The daily prices for the period are distributed with arithmetic mean of 414.3. The median price for the last 90 days is 415.66. The company experienced 2:1 stock split on 24th of August 2000.| Open | High | Low | Close | Volume | ||
05/02/2024 | 402.14 | 403.91 | 403.91 | 403.91 | ||
| 05/01/2024 | 392.81 | 406.90 | 392.47 | 402.14 | 1,236,091 | |
| 04/30/2024 | 396.20 | 396.69 | 391.70 | 392.81 | 1,727,384 | |
| 04/29/2024 | 397.48 | 399.31 | 394.35 | 396.20 | 604,507 | |
| 04/26/2024 | 393.52 | 399.63 | 393.49 | 397.48 | 677,777 | |
| 04/25/2024 | 402.44 | 403.88 | 393.00 | 397.70 | 787,230 | |
| 04/24/2024 | 404.50 | 406.83 | 399.29 | 400.76 | 806,500 | |
| 04/23/2024 | 404.00 | 406.74 | 403.47 | 404.91 | 1,069,746 | |
| 04/22/2024 | 397.73 | 406.34 | 396.00 | 399.92 | 1,325,042 | |
| 04/19/2024 | 394.72 | 396.98 | 391.25 | 394.28 | 1,323,803 | |
| 04/18/2024 | 394.19 | 396.14 | 391.02 | 393.48 | 948,806 | |
| 04/17/2024 | 394.94 | 398.11 | 392.03 | 393.10 | 880,949 | |
| 04/16/2024 | 396.88 | 398.49 | 392.81 | 394.17 | 693,810 | |
| 04/15/2024 | 400.00 | 402.49 | 396.69 | 397.36 | 1,372,621 | |
| 04/12/2024 | 396.57 | 400.14 | 393.76 | 396.55 | 1,164,746 | |
| 04/11/2024 | 404.30 | 404.69 | 398.85 | 400.23 | 1,060,233 | |
| 04/10/2024 | 399.89 | 401.00 | 394.84 | 397.58 | 1,012,069 | |
| 04/09/2024 | 406.00 | 406.45 | 399.30 | 404.48 | 721,018 | |
| 04/08/2024 | 403.45 | 404.60 | 399.00 | 404.22 | 745,908 | |
| 04/05/2024 | 404.29 | 409.93 | 400.83 | 406.67 | 695,660 | |
| 04/04/2024 | 412.64 | 412.64 | 403.15 | 404.01 | 957,186 | |
| 04/03/2024 | 409.45 | 414.96 | 408.25 | 408.81 | 728,589 | |
| 04/02/2024 | 419.00 | 420.87 | 406.73 | 409.42 | 974,479 | |
| 04/01/2024 | 420.43 | 421.45 | 414.74 | 420.48 | 767,528 | |
| 03/28/2024 | 419.48 | 420.67 | 415.06 | 418.01 | 1,053,576 | |
| 03/27/2024 | 420.30 | 420.42 | 412.65 | 417.32 | 905,394 | |
| 03/26/2024 | 417.38 | 419.40 | 414.86 | 418.46 | 952,065 | |
| 03/25/2024 | 415.66 | 418.24 | 414.97 | 416.03 | 721,971 | |
| 03/22/2024 | 417.75 | 417.75 | 412.19 | 415.66 | 808,164 | |
| 03/21/2024 | 415.61 | 419.26 | 414.09 | 415.71 | 878,823 | |
| 03/20/2024 | 414.51 | 414.51 | 409.02 | 412.11 | 793,314 | |
| 03/19/2024 | 412.51 | 415.70 | 411.10 | 415.20 | 844,417 | |
| 03/18/2024 | 409.25 | 415.50 | 409.25 | 411.38 | 926,245 | |
| 03/15/2024 | 409.18 | 411.64 | 406.97 | 407.69 | 1,894,452 | |
| 03/14/2024 | 414.01 | 414.98 | 407.11 | 408.77 | 1,007,523 | |
| 03/13/2024 | 414.46 | 415.92 | 410.39 | 413.20 | 764,165 | |
| 03/12/2024 | 413.00 | 416.11 | 409.02 | 412.45 | 866,850 | |
| 03/11/2024 | 414.00 | 416.71 | 409.52 | 414.47 | 1,242,142 | |
| 03/08/2024 | 412.34 | 416.25 | 410.95 | 413.59 | 807,510 | |
| 03/07/2024 | 415.15 | 418.16 | 410.23 | 410.54 | 922,951 | |
| 03/06/2024 | 414.23 | 418.22 | 410.67 | 411.85 | 1,204,971 | |
| 03/05/2024 | 424.87 | 425.49 | 414.04 | 415.44 | 1,113,593 | |
| 03/04/2024 | 432.73 | 433.85 | 422.16 | 424.03 | 1,072,927 | |
| 03/01/2024 | 423.20 | 433.67 | 423.00 | 432.76 | 1,091,462 | |
| 02/29/2024 | 429.18 | 429.18 | 420.30 | 420.74 | 1,844,619 | |
| 02/28/2024 | 429.60 | 433.49 | 425.71 | 426.97 | 778,845 | |
| 02/27/2024 | 434.13 | 437.00 | 430.52 | 430.92 | 907,635 | |
| 02/26/2024 | 425.70 | 434.26 | 425.70 | 433.48 | 787,655 | |
| 02/23/2024 | 430.00 | 434.47 | 429.07 | 430.11 | 746,936 | |
| 02/22/2024 | 419.85 | 429.81 | 419.85 | 426.78 | 1,031,975 | |
| 02/21/2024 | 421.77 | 424.00 | 414.80 | 419.63 | 906,525 | |
| 02/20/2024 | 420.79 | 425.00 | 416.17 | 420.64 | 1,040,374 | |
| 02/16/2024 | 427.04 | 427.04 | 420.97 | 422.20 | 1,176,401 | |
| 02/15/2024 | 419.16 | 427.40 | 418.61 | 426.29 | 1,473,593 | |
| 02/14/2024 | 418.38 | 420.45 | 414.26 | 417.88 | 1,133,112 | |
| 02/13/2024 | 417.36 | 419.42 | 412.77 | 416.04 | 1,163,878 | |
| 02/12/2024 | 420.24 | 421.30 | 415.28 | 418.53 | 1,340,000 | |
| 02/09/2024 | 425.96 | 425.96 | 419.51 | 422.91 | 1,169,486 | |
| 02/08/2024 | 420.28 | 424.48 | 417.14 | 423.06 | 1,380,000 | |
| 02/07/2024 | 416.74 | 426.72 | 416.74 | 419.08 | 1,990,000 | |
| 02/06/2024 | 428.76 | 430.99 | 410.80 | 416.13 | 4,500,000 |
About Vertex Pharmaceuticals Stock history
Vertex Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vertex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vertex Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vertex Pharmaceuticals stock prices may prove useful in developing a viable investing in Vertex Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 260.5 M | 153.1 M | |
| Net Income Applicable To Common Shares | 3.8 B | 4 B |
Vertex Pharmaceuticals Quarterly Net Working Capital |
|
Vertex Pharmaceuticals Stock Technical Analysis
Vertex Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Vertex Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vertex Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Vertex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vertex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.18) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Vertex Stock analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.181 | Earnings Share 13.9 | Revenue Per Share 38.297 | Quarterly Revenue Growth 0.093 | Return On Assets 0.1317 |
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.